Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Liu, Yuchen ^a,b,c   Han, Yonghua ^a,c   Zhang, Hu ^a,b   Nie, Liping ^a   Jiang, Zhimao ^a   Fa, Pingping ^a   Gui, Yaoting ^a   Cai, Zhiming ^a,c  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 182; MICRORNA 183; MICRORNA 210; MICRORNA 96; MICRORNA MOWER; RENILLA LUCIFERIN 2 MONOOXYGENASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; BLADDER CANCER; CANCER CELL; CANCER INHIBITION; CELL MOTILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TANDEM REPEAT;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

RENILLA LUCIFERASE;

EID: 84871292051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052280     Document Type: Article

References (41)

1. Montironi R, Lopez-Beltran A, (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13(2): 143-153.
2. Parekh DJ, Bochner BH, Dalbagni G, (2006) Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. J Clin Oncol 24(35): 5519-5527.
3. Lei AQ, Cheng L, Pan CX, (2011) Current treatment of metastatic bladder cancer and future directions. Expert Rev Anticancer Ther 11(12): 1851-1862.
4. Racioppi M, D'Agostino D, Totaro A, Pinto F, Sacco E, et al. (2012) Value of current chemotherapy and surgery in advanced and metastatic bladder cancer. Urol Int 88(3): 249-258.
5. Marta GN, Hanna SA, Gadia R, Correa SF, Silva JL, et al. (2012) The role of radiotherapy in urinary bladder cancer: current status. Int Braz J Urol 38(2): 144-153.
6. Carradori S, Cristini C, Secci D, Gulia C, Gentile V, et al. (2012) Current and emerging strategies in bladder cancer. Anticancer Agents Med Chem 12(6): 589-603.
7. Culler SJ, Hoff KG, Smolke CD, (2010) Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 330(6008): 1251-1255.
8. Karlsson M, Weber W, (2012) Therapeutic synthetic gene networks. Curr Opin Biotechnol 23: 1-9.
9. Shankar S, Pillai MR, (2011) Translating cancer research by synthetic biology. Mol Biosyst 7(6): 1802-1810.
10. Nissim L, Bar-Ziv RH, (2010) A tunable dual-promoter integrator for targeting of cancer cells. Mol Syst Biol 6: 444.
11. Xie Z, Wroblewska L, Prochazka L, Weiss R, Benenson Y, (2011) Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333(6047): 1307-1311.
12. Pasquinelli AE, (2011) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13(4): 271-282.
13. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, et al. (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59(5): 671-681.
14. Iorio MV, Croce CM, (2012) microRNA involvement in human cancer. Carcinogenesis 33(6): 1126-1133.
15. Han Y, Chen J, Zhao X, Liang C, Wang Y, et al. (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6(3): e18286.
16. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, et al. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465(7301): 1033-1038.
17. Muro EM, Mah N, Andrade-Navarro MA, (2011) Functional evidence of post-transcriptional regulation by pseudogenes. Biochimie 93(11): 1916-1921.
18. Cazalla D, Yario T, Steitz JA, (2010) Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328(5985): 1563-1566.
19. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, et al. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305(5689): 1437-1441.
20. Saetrom P, Heale BS, Snøve O Jr, Aagaard L, Alluin J, et al. (2007) Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res 35(7): 2333-2342.
21. Cho WC, (2012) MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin Ther Targets 16(8): 747-759.
22. Cho WC, (2012) Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin Ther Targets 16(4): 345-350.
23. Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, et al. (2011) miR-183-96-182 cluster is over-expressed in prostate tissue and regulates zinc homeo-stasis in prostate cells. J Biol Chem 286(52): 44503-44511.
24. Lehmann U, Streichert T, Otto B, Albat C, Hasemeier B, et al. (2010) Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 10: 109.
25. Zhu W, Liu X, He J, Chen D, Hunag Y, et al. (2011) Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11: 393.
26. Weeraratne SD, Amani V, Teider N, Pierre-Francois J, Winter D, et al. (2012) Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol 123(4): 539-552.
27. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, et al. (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102(3): 522-529.
28. Lin H, Dai T, Xiong H, Zhao X, Chen X, et al. (2010) Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5(12): e15797.
29. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, et al. (2009) Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 106(6): 1814-1819.
30. Sarver AL, Li L, Subramanian S, (2010) MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 70(23): 9570-9580.
31. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, et al. (2008) hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14(5): 1340-1348.
32. Yang W, Sun T, Cao J, Liu F, Tian Y, et al. (2012) Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 318(8): 944-954.
33. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, et al. (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283(23): 15878-15883.
34. Wu P, Hu YZ, (2010) PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress. Curr Med Chem 17(35): 4326-4341.
35. Nardinocchi L, Pantisano V, Puca R, Porru M, Aiello A, et al. (2010) Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo. PLoS One 5(12): e15048.
36. Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, et al. (2008) miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7(2): 255-264.
37. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, et al. (2009) Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 35(6): 856-967.
38. Noman MZ, Buart S, Romero P, Ketari S, Janji B, et al. (2012) Hypoxia-inducible miR-210 regulates the susceptibility of tumor Cells to lysis by cytotoxic T cells. Cancer Res. 72(18): 4629-4641.
39. Kim HW, Haider HK, Jiang S, Ashraf M, (2009) Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 284(48): 33161-33168.
40. MosmannT (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2): 55-63.
41. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2): 329-333.